STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

SMMT SUMMIT THERAPEUTICS INCORPORATED StockScouter® Report

3

StockScouter® Score

SUMMIT THERAPEUTICS INCORPORATED, a mid cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Two or more executives, directors or major shareholders – including one high-level executive -- purchased a large number of shares recently. Very positive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • One or more analysts has significantly decreased quarterly earnings estimates for SMMT. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 80% done.
Low
High

Core Model Grades

D
A
N/A
B

Previous Ratings

1
1
1